Blueprint Genetics evaluates Twist Custom Panels for hereditary disease

Blueprint Genetics evaluates Twist Custom Panels for hereditary disease | AGBT 2019

Dr. Pertteli Salmenperä of Blueprint Genetics details the importance of coverage uniformity in NGS testing of hereditary disorders

View the Webinar

Presented by

Covered in this Webinar

Learn about the importance of quality sequencing in clinical adoption of NGS for Rare Disease testing.

Learn about the process of building an optimizing a targeted clinical panel for Rare Disease Testing.

Hear how Twist Target Enrichment Panels can be designed, tested and optimized for exceptional performance.

Dr. Salmenperä discusses the importance of sequencing quality and consistency when driving adoption of Next Generation Sequencing approaches in a clinical setting.

Share your details to Watch the Webinar

Genes

Oligo Pools

NGS Target Enrichment Solutions

Variant Libraries

Synthetic Controls

Antibody Discovery

Blueprint Genetics evaluates Twist Custom Panels for hereditary disease | AGBT 2019

Related Resources

Highly Sensitive Methylation Detection Using Enzymatic Methyl-seq and Twist Target Enrichment

Twist Targeted Methylation Sequencing Protocol

NGS Methylation Detection System